First, limited by human, material, and financial resources and other factors, and due to the absence of fasting insulin measurement and nonevaluation of HOMA-IR in the Kailuan Study [41], it was impossible to compare the differences between HOMA-IR and TyG index on early-onset stroke. This evidence concerns the gene INS and Stroke.